| Year |
Citation |
Score |
| 2023 |
Benedetti DJ, Varela CR, Renfro LA, Tornwall B, Dix DB, Ehrlich PF, Glick RD, Kalapurakal J, Perlman E, Gratias E, Seibel NL, Geller JI, Khanna G, Malogolowkin M, Grundy P, et al. Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5. Cancer. PMID 37933882 DOI: 10.1002/cncr.35099 |
0.32 |
|
| 2023 |
Oosterom N, Gooskens SLM, Renfro LA, Perlman EJ, van den Heuvel-Eibrink MM, Hamilton TE, Green DM, Grundy PE, Daw NC, Geller JI, Dome JS, Fernandez CV, Mullen EA. Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2202555. PMID 37343199 DOI: 10.1200/JCO.22.02555 |
0.369 |
|
| 2021 |
Dome JS, Mullen EA, Dix DB, Gratias EJ, Ehrlich PF, Daw NC, Geller JI, Chintagumpala M, Khanna G, Kalapurakal JA, Renfro LA, Perlman EJ, Grundy PE, Fernandez CV. Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor. Journal of the National Comprehensive Cancer Network : Jnccn. 19: 978-985. PMID 34416705 DOI: 10.6004/jnccn.2021.7070 |
0.339 |
|
| 2020 |
Ehrlich PF, Chi YY, Chintagumpala MM, Hoffer FA, Perlman EJ, Kalapurakal JA, Tornwall B, Warwick A, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, ... ... Grundy PE, et al. Results of treatment for patients with multicentric or bilaterally predisposed unilateral Wilms tumor (AREN0534): A report from the Children's Oncology Group. Cancer. PMID 32459384 DOI: 10.1002/Cncr.32958 |
0.385 |
|
| 2020 |
Sandberg JK, Chi YY, Smith EA, Servaes S, Hoffer FA, Mullen EA, Perlman EJ, Tornwall B, Ehrlich PF, Geller JI, Grundy PE, Fernandez CV, Dome JS, Khanna G. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2. Ajr. American Journal of Roentgenology. 1-8. PMID 32160052 DOI: 10.2214/Ajr.19.22301 |
0.405 |
|
| 2020 |
Daw NC, Chi YY, Kalapurakal JA, Kim Y, Hoffer FA, Geller JI, Perlman EJ, Ehrlich PF, Mullen EA, Warwick AB, Grundy PE, Paulino AC, Gratias E, Ward D, Anderson JR, et al. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901265. PMID 32134700 DOI: 10.1200/Jco.19.01265 |
0.353 |
|
| 2019 |
Dix DB, Fernandez CV, Chi YY, Mullen EA, Geller JI, Gratias EJ, Khanna G, Kalapurakal JA, Perlman EJ, Seibel NL, Ehrlich PF, Malogolowkin M, Anderson J, Gastier-Foster J, Shamberger RC, ... ... Grundy PE, et al. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801972. PMID 31449468 DOI: 10.1200/Jco.18.01972 |
0.367 |
|
| 2018 |
Mullen EA, Chi YY, Hibbitts E, Anderson JR, Steacy KJ, Geller JI, Green DM, Khanna G, Malogolowkin MH, Grundy PE, Fernandez CV, Dome JS. Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800076. PMID 30335557 DOI: 10.1200/Jco.18.00076 |
0.3 |
|
| 2018 |
Seibel NL, Chi YY, Perlman EJ, Tian J, Sun J, Anderson JR, Ritchey ML, Thomas PR, Miser J, Kalapurakal JA, Grundy PE, Green DM. Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5). Pediatric Blood & Cancer. e27450. PMID 30255545 DOI: 10.1002/pbc.27450 |
0.339 |
|
| 2016 |
Fernandez CV, Perlman EJ, Mullen EA, Chi YY, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, Tian J, Geller JI, ... Grundy PE, et al. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532. Annals of Surgery. PMID 27811504 DOI: 10.1097/Sla.0000000000001716 |
0.365 |
|
| 2016 |
Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27400937 DOI: 10.1200/Jco.2015.66.1140 |
0.454 |
|
| 2016 |
Krepischi ACV, Maschietto M, Ferreira EN, Silva AG, Costa SS, da Cunha IW, Barros BDF, Grundy PE, Rosenberg C, Carraro DM. Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors. Molecular Cytogenetics. 9: 20. PMID 26913079 DOI: 10.1186/s13039-016-0227-y |
0.41 |
|
| 2015 |
Fernandez CV, Perlman E, Mullen EA, Chi Y, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, An Q, Geller JI, ... Grundy PE, et al. Clinical outcome and biological predictors of relapse following nephrectomy only for very low risk Wilms tumor (VLR WT): A report from Children’s Oncology Group AREN0532. Journal of Clinical Oncology. 33: 10023-10023. DOI: 10.1200/Jco.2015.33.15_Suppl.10023 |
0.327 |
|
| 2015 |
Dix DB, Fernandez CV, Chi Y, Anderson JR, Mullen EA, Geller JI, Gratias EJ, Khanna G, Kalapurakal JA, Perlman EJ, Seibel N, Ehrlich PF, Malogolowkin MH, Gow KW, Hamilton TE, ... Grundy PE, et al. Augmentation of therapy for favorable-histology Wilms Tumor with combined loss of heterozygosity of chromosomes 1p and 16q: A report from the Children’s Oncology Group studies AREN0532 and AREN0533. Journal of Clinical Oncology. 33: 10009-10009. DOI: 10.1200/Jco.2015.33.15_Suppl.10009 |
0.354 |
|
| 2015 |
Zong X, Pole JD, Grundy P, Mahmud SM, Parker L, Hung RJ. Abstract 3713: Second malignant neoplasms after non-CNS embryonal tumors in North America Cancer Research. 75: 3713-3713. DOI: 10.1158/1538-7445.Am2015-3713 |
0.371 |
|
| 2014 |
Green DM, Breslow NE, D'Angio GJ, Malogolowkin MH, Ritchey ML, Evans AE, Beckwith JB, Perlman EJ, Shamberger RC, Peterson S, Grundy PE, Dome JS, Thomas PR, Kalapurakal JA. Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Pediatric Blood & Cancer. 61: 134-9. PMID 24038736 DOI: 10.1002/Pbc.24658 |
0.378 |
|
| 2014 |
Daw NC, Anderson JR, Hoffer FA, Geller JI, Kalapurakal JA, Perlman EJ, Ehrlich PF, Mullen EA, Gratias EJ, Grundy PE, Dome JS. A phase 2 study of vincristine and irinotecan in metastatic diffuse anaplastic Wilms tumor: Results from the Children’s Oncology Group AREN0321 study. Journal of Clinical Oncology. 32: 10032-10032. DOI: 10.1200/Jco.2014.32.15_Suppl.10032 |
0.323 |
|
| 2014 |
Mullen EA, Geller JI, Gratias EJ, Perlman EJ, Ehrlich PF, Khanna G, Naranjo A, He Y, Hamilton TE, Ferrer FA, Glick RD, Gow KW, Barnhart DC, Kandel JJ, Dasgupta R, ... ... Grundy PE, et al. Real-time central review: A report of the first 3,000 patients enrolled on the Children’s Oncology Group Renal Tumor Biology and Risk Stratification protocol AREN03B2. Journal of Clinical Oncology. 32: 10000-10000. DOI: 10.1200/Jco.2014.32.15_Suppl.10000 |
0.333 |
|
| 2013 |
Gratias EJ, Jennings LJ, Anderson JR, Dome JS, Grundy P, Perlman EJ. Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Cancer. 119: 3887-94. PMID 23983061 DOI: 10.1002/cncr.28239 |
0.416 |
|
| 2013 |
Ehrlich PF, Anderson JR, Ritchey ML, Dome JS, Green DM, Grundy PE, Perlman EJ, Kalapurakal JA, Breslow NE, Shamberger RC. Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1196-201. PMID 23382471 DOI: 10.1200/Jco.2011.41.1165 |
0.32 |
|
| 2013 |
Gow KW, Barnhart DC, Hamilton TE, Kandel JJ, Chen MK, Ferrer FA, Price MR, Mullen EA, Geller JI, Gratias EJ, Rosen N, Khanna G, Naranjo A, Ritchey ML, Grundy PE, et al. Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. Journal of Pediatric Surgery. 48: 34-8. PMID 23331790 DOI: 10.1016/J.Jpedsurg.2012.10.015 |
0.359 |
|
| 2013 |
Routh JC, Grundy PE, Anderson JR, Retik AB, Kurek KC. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. The Journal of Urology. 189: 1487-92. PMID 23154206 DOI: 10.1016/j.juro.2012.11.012 |
0.404 |
|
| 2013 |
Kalapurakal JA, Perlman EJ, Seibel NL, Ritchey M, Dome JS, Grundy PE. Outcomes of patients with revised stage i clear cell sarcoma of kidney treated in national wilms tumor studies 1-5 International Journal of Radiation Oncology Biology Physics. 85: 428-431. PMID 22658515 DOI: 10.1016/j.ijrobp.2012.04.023 |
0.315 |
|
| 2013 |
Gratias EJ, Jennings LJ, Anderson JR, Dome J, Grundy PE, Perlman E. Prognostic implications of gain of 1q in favorable histology Wilms tumor: A report from the Children’s Oncology Group. Journal of Clinical Oncology. 31: 10014-10014. DOI: 10.1200/jco.2013.31.15_suppl.10014 |
0.325 |
|
| 2013 |
Maschietto M, Chagtai T, Popov SD, Sebire N, Vujanic G, Hing S, Grundy P, Dome JS, Pritchard-Jones K, Williams RD. Abstract 3829: TP53 mutation status defines two distinct classes of diffuse anaplastic Wilms tumor. Cancer Research. 73: 3829-3829. DOI: 10.1158/1538-7445.Am2013-3829 |
0.411 |
|
| 2013 |
Turnbull C, Perdeaux ER, Pernet D, Naranjo A, Renwick A, Seal S, Munoz-Xicola RM, Hanks S, Slade I, Zachariou A, Warren-Perry M, Ruark E, Gerrard M, Hale J, Hewitt M, ... ... Grundy P, et al. Erratum: A genome-wide association study identifies susceptibility loci for Wilms tumor Nature Genetics. 45: 962-962. DOI: 10.1038/ng0813-962a |
0.326 |
|
| 2012 |
Kulkarni K, Desai S, Grundy P, Sergi C. Infantile myofibromatosis: report on a family with autosomal dominant inheritance and variable penetrance. Journal of Pediatric Surgery. 47: 2312-5. PMID 23217896 DOI: 10.1016/J.Jpedsurg.2012.09.046 |
0.322 |
|
| 2012 |
Turnbull C, Perdeaux ER, Pernet D, Naranjo A, Renwick A, Seal S, Munoz-Xicola RM, Hanks S, Slade I, Zachariou A, Warren-Perry M, Ruark E, Gerrard M, Hale J, Hewitt M, ... ... Grundy P, et al. A genome-wide association study identifies susceptibility loci for Wilms tumor. Nature Genetics. 44: 681-4. PMID 22544364 DOI: 10.1038/Ng.2251 |
0.489 |
|
| 2012 |
Scott RH, Murray A, Baskcomb L, Turnbull C, Loveday C, Al-Saadi R, Williams R, Breatnach F, Gerrard M, Hale J, Kohler J, Lapunzina P, Levitt GA, Picton S, Pizer B, ... ... Grundy P, et al. Stratification of Wilms tumor by genetic and epigenetic analysis. Oncotarget. 3: 327-35. PMID 22470196 DOI: 10.18632/Oncotarget.468 |
0.465 |
|
| 2012 |
Schmitt J, Heisel S, Keller A, Leidinger P, Ludwig N, Habel N, Furtwängler R, Nourkami-Tutdibi N, Wegert J, Grundy P, Gessler M, Graf N, Lenhof HP, Meese E. Multicenter study identified molecular blood-born protein signatures for Wilms Tumor. International Journal of Cancer. Journal International Du Cancer. 131: 673-82. PMID 21913182 DOI: 10.1002/Ijc.26419 |
0.41 |
|
| 2012 |
Khanna G, Rosen N, Anderson JR, Ehrlich PF, Dome JS, Gow KW, Perlman E, Barnhart D, Karolczuk K, Grundy P. Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 58: 551-5. PMID 21674767 DOI: 10.1002/Pbc.23222 |
0.479 |
|
| 2012 |
Turnbull C, Perdeaux ER, Pernet D, Naranjo A, Renwick A, Seal S, Munoz-Xicola RM, Hanks S, Slade I, Zachariou A, Warren-Perry M, Ruark E, Gerrard M, Hale J, Hewitt M, ... ... Grundy P, et al. Erratum: A genome-wide association study identifies susceptibility loci for Wilms tumor Nature Genetics. 44: 831-831. DOI: 10.1038/ng0712-831c |
0.326 |
|
| 2012 |
Thangada S, Hla T, Grundy P, Ferrer F. 150 CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR 1 AND 2 LEVELS ARE ALTERED IN WILM'S TUMOR Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.200 |
0.348 |
|
| 2011 |
Williams RD, Al-Saadi R, Natrajan R, Mackay A, Chagtai T, Little S, Hing SN, Fenwick K, Ashworth A, Grundy P, Anderson JR, Dome JS, Perlman EJ, Jones C, Pritchard-Jones K. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes, Chromosomes & Cancer. 50: 982-95. PMID 21882282 DOI: 10.1002/Gcc.20907 |
0.495 |
|
| 2011 |
Segers H, van den Heuvel-Eibrink MM, Pritchard-Jones K, Coppes MJ, Aitchison M, Bergeron C, de Camargo B, Dome JS, Grundy P, Gatta G, Graf N, Grundy P, Kalapurakal JA, de Kraker J, Perlman EJ, et al. Management of adults with Wilms' tumor: recommendations based on international consensus. Expert Review of Anticancer Therapy. 11: 1105-13. PMID 21806333 DOI: 10.1586/Era.11.76 |
0.422 |
|
| 2011 |
Perlman EJ, Grundy PE, Anderson JR, Jennings LJ, Green DM, Dome JS, Shamberger RC, Ruteshouser EC, Huff V. WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 698-703. PMID 21189373 DOI: 10.1200/Jco.2010.31.5192 |
0.336 |
|
| 2010 |
Kalapurakal JA, Green DM, Haase G, Anderson JR, Dome JS, Grundy PE. Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5. International Journal of Radiation Oncology, Biology, Physics. 77: 554-8. PMID 20457352 DOI: 10.1016/j.ijrobp.2009.04.081 |
0.344 |
|
| 2010 |
Shamberger RC, Anderson JR, Breslow NE, Perlman EJ, Beckwith JB, Ritchey ML, Haase GM, Donaldson M, Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer PD, Kletzel M, Thomas PR, et al. Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Annals of Surgery. 251: 555-8. PMID 20142733 DOI: 10.1097/Sla.0B013E3181C0E5D7 |
0.334 |
|
| 2010 |
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, Thomas PR, Grundy P, Green DM, D'Angio GJ. Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group. International Journal of Radiation Oncology, Biology, Physics. 76: 201-6. PMID 19395185 DOI: 10.1016/J.Ijrobp.2009.01.046 |
0.469 |
|
| 2009 |
Sredni ST, Gadd S, Huang CC, Breslow N, Grundy P, Green DM, Dome JS, Shamberger RC, Beckwith JB, Perlman EJ. Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6800-9. PMID 19903788 DOI: 10.1158/1078-0432.Ccr-09-0312 |
0.467 |
|
| 2009 |
Drake KM, Ruteshouser EC, Natrajan R, Harbor P, Wegert J, Gessler M, Pritchard-Jones K, Grundy P, Dome J, Huff V, Jones C, Aldred MA. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: Putative role for miR-562 Clinical Cancer Research. 15: 5985-5992. PMID 19789318 DOI: 10.1158/1078-0432.Ccr-09-1065 |
0.526 |
|
| 2009 |
Ehrlich PF, Ferrer FA, Ritchey ML, Anderson JR, Green DM, Grundy PE, Dome JS, Kalapurakal JA, Perlman EJ, Shamberger RC. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group. Annals of Surgery. 250: 642-8. PMID 19730241 DOI: 10.1097/Sla.0B013E3181B76F20 |
0.406 |
|
| 2009 |
Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE, Green DM, Fritsch MK, Perlman EJ. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1770-8. PMID 19208794 DOI: 10.1158/1078-0432.Ccr-08-1030 |
0.352 |
|
| 2009 |
Fernandez CV, Anderson J, Breslow NE, Dome JS, Grundy PE, Perlman EJ, Green DM. Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 52: 254-8. PMID 18989885 DOI: 10.1002/Pbc.21809 |
0.339 |
|
| 2008 |
Tamimi Y, Ekuere U, Laughton N, Grundy P. WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis. Neoplasia (New York, N.Y.). 10: 1470-80. PMID 19048125 DOI: 10.1593/Neo.08442 |
0.381 |
|
| 2008 |
Maschietto M, de Camargo B, Brentani H, Grundy P, Sredni ST, Torres C, Mota LD, Cunha IW, Patrão DF, Costa CM, Soares FA, Brentani RR, Carraro DM. Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development. Oncology. 75: 81-91. PMID 18784435 DOI: 10.1159/000155210 |
0.401 |
|
| 2008 |
Kim MK, Mason JM, Li CM, Berkofsky-Fessler W, Jiang L, Choubey D, Grundy PE, Tycko B, Licht JD. A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16. Neoplasia (New York, N.Y.). 10: 69-78. PMID 18231640 DOI: 10.1593/Neo.07869 |
0.453 |
|
| 2008 |
van den Heuvel-Eibrink MM, Grundy P, Graf N, Pritchard-Jones K, Bergeron C, Patte C, van Tinteren H, Rey A, Langford C, Anderson JR, de Kraker J. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatric Blood & Cancer. 50: 1130-4. PMID 18095319 DOI: 10.1002/Pbc.21389 |
0.526 |
|
| 2008 |
Kaste SC, Dome JS, Babyn PS, Graf NM, Grundy P, Godzinski J, Levitt GA, Jenkinson H. Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatric Radiology. 38: 2-17. PMID 18026723 DOI: 10.1007/S00247-007-0687-7 |
0.303 |
|
| 2008 |
Natrajan R, Warren W, Messahel B, Reis-Filho JS, Brundler MA, Dome JS, Grundy PE, Vujanic G, Pritchard-Jones K, Jones C. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours. Journal of Clinical Pathology. 61: 95-102. PMID 17369505 DOI: 10.1136/Jcp.2007.047159 |
0.307 |
|
| 2007 |
Natrajan R, Williams RD, Grigoriadis A, Mackay A, Fenwick K, Ashworth A, Dome JS, Grundy PE, Pritchard-Jones K, Jones C. Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH. Genes, Chromosomes & Cancer. 46: 607-15. PMID 17370329 DOI: 10.1002/gcc.20446 |
0.302 |
|
| 2007 |
Tamimi Y, Ziebart K, Desaulniers N, Dietrich K, Grundy P. Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor. Genes, Chromosomes & Cancer. 46: 327-35. PMID 17243164 DOI: 10.1002/Gcc.20413 |
0.473 |
|
| 2007 |
Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatric Blood & Cancer. 48: 493-9. PMID 16547940 DOI: 10.1002/Pbc.20822 |
0.34 |
|
| 2006 |
Natrajan R, Little SE, Reis-Filho JS, Hing L, Messahel B, Grundy PE, Dome JS, Schneider T, Vujanic GM, Pritchard-Jones K, Jones C. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors Clinical Cancer Research. 12: 7284-7293. PMID 17189400 DOI: 10.1158/1078-0432.CCR-06-1567 |
0.446 |
|
| 2006 |
Natrajan R, Reis-Filho JS, Little SE, Messahel B, Brundler MA, Dome JS, Grundy PE, Vujanic GM, Pritchard-Jones K, Jones C. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse Cancer Research. 66: 11148-11155. PMID 17145858 DOI: 10.1158/0008-5472.CAN-06-1931 |
0.451 |
|
| 2006 |
Hamilton TE, Green DM, Perlman EJ, Argani P, Grundy P, Ritchey ML, Shamberger RC. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study. Journal of Pediatric Surgery. 41: 1641-4. PMID 17011261 DOI: 10.1016/J.Jpedsurg.2006.05.053 |
0.507 |
|
| 2006 |
Tamimi Y, Dietrich K, Stone K, Grundy P. Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor. Mutation Research. 601: 46-50. PMID 16814811 DOI: 10.1016/J.Mrfmmm.2006.05.025 |
0.444 |
|
| 2006 |
Ehrlich PF, Hamilton TE, Grundy P, Ritchey M, Haase G, Shamberger RC. The value of surgery in directing therapy for patients with Wilms' tumor with pulmonary disease. A report from the National Wilms' Tumor Study Group (National Wilms' Tumor Study 5). Journal of Pediatric Surgery. 41: 162-7; discussion 16. PMID 16410127 DOI: 10.1016/J.Jpedsurg.2005.10.020 |
0.372 |
|
| 2006 |
Desrosiers RR, Rivard ME, Grundy PE, Annabi B. Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Pediatric Blood & Cancer. 46: 40-9. PMID 16106426 DOI: 10.1002/pbc.20566 |
0.397 |
|
| 2005 |
Green DM, Malogolowkin M, Cotton C, Breslow N, Perlman E, Miser J, Ritchey M, Thomas P, Grundy P, D'Angio G. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D. A report from the National Wilms Tumor Study (NWTS) Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8551. PMID 27944695 DOI: 10.1200/Jco.2005.23.16_Suppl.8551 |
0.445 |
|
| 2005 |
Dome JS, Green DM, Cotton CA, Breslow NE, Perlman EJ, Miser J, Ritchey ML, Shamberger R, Thomas PR, Grundy PE. Treatment of anaplastic Wilms tumor: A report from the National Wilms Tumor Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8508. PMID 27944564 DOI: 10.1200/Jco.2005.23.16_Suppl.8508 |
0.431 |
|
| 2005 |
Niemitz EL, Feinberg AP, Brandenburg SA, Grundy PE, DeBaun MR. Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor. American Journal of Human Genetics. 77: 887-91. PMID 16252245 DOI: 10.1086/497540 |
0.391 |
|
| 2005 |
Grundy P, Perlman E, Rosen NS, Warwick AB, Glade Bender J, Ehrlich P, Hoffer FA, Lee ND. Current issues in Wilms tumor management. Current Problems in Cancer. 29: 221-60. PMID 16216623 DOI: 10.1016/J.Currproblcancer.2005.08.002 |
0.422 |
|
| 2005 |
Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7312-21. PMID 16129848 DOI: 10.1200/Jco.2005.01.2799 |
0.372 |
|
| 2005 |
Ehrlich PF, Ritchey ML, Hamilton TE, Haase GM, Ou S, Breslow N, Grundy P, Green D, Norkool P, Becker J, Shamberger RC. Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5. Journal of Pediatric Surgery. 40: 208-12; discussion 2. PMID 15868587 DOI: 10.1016/J.Jpedsurg.2004.09.044 |
0.488 |
|
| 2005 |
Safford SD, Freemerman AJ, Langdon S, Bentley R, Goyeau D, Grundy PE, Skinner MA. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors. Journal of Pediatric Surgery. 40: 341-8. PMID 15750927 DOI: 10.1016/j.jpedsurg.2004.10.030 |
0.338 |
|
| 2005 |
Miller MA, Karacay B, Breslow NE, Li S, O'Dorisio MS, Grundy PE, Sandler AD. Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors. Journal of Pediatric Hematology/Oncology. 27: 11-4. PMID 15654272 DOI: 10.1097/01.Mph.0000149961.71266.27 |
0.392 |
|
| 2005 |
Kalapurakal J, Breslow N, Ritchey M, Shamberger R, Haase G, Grundy P, Green D, Thomas D, D’Angio G. Influence of Radiation Therapy and Doxorubicin on Abdominal Tumor Recurrence Following Tumor Spillage Among Patients with Favorable Histology Wilms Tumor in NWTS-3 and -4 International Journal of Radiation Oncology*Biology*Physics. 63: S22-S23. DOI: 10.1016/J.Ijrobp.2005.07.045 |
0.506 |
|
| 2004 |
Kalapurakal JA, Nan B, Norkool P, Coppes M, Perlman E, Beckwith B, Ritchey M, Breslow N, Grundy P, D'angio GJ, Green DM, Thomas PR. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. International Journal of Radiation Oncology, Biology, Physics. 60: 1379-84. PMID 15590168 DOI: 10.1016/J.Ijrobp.2004.05.057 |
0.394 |
|
| 2004 |
Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D'Agati V, Licht JD, Tycko B. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. The American Journal of Pathology. 165: 1943-53. PMID 15579438 DOI: 10.1016/S0002-9440(10)63246-4 |
0.314 |
|
| 2004 |
Anglesio MS, Evdokimova V, Melnyk N, Zhang L, Fernandez CV, Grundy PE, Leach S, Marra MA, Brooks-Wilson AR, Penninger J, Sorensen PH. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney. Human Molecular Genetics. 13: 2061-74. PMID 15254018 DOI: 10.1093/Hmg/Ddh215 |
0.384 |
|
| 2003 |
Qualman SJ, Bowen J, Amin MB, Srigley JR, Grundy PE, Perlman EJ. Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood. Archives of Pathology & Laboratory Medicine. 127: 1280-9. PMID 14521468 DOI: 10.1043/1543-2165(2003)127<1280:PFTEOS>2.0.CO;2 |
0.405 |
|
| 2003 |
Schuster AE, Schneider DT, Fritsch MK, Grundy P, Perlman EJ. Genetic and genetic expression analyses of clear cell sarcoma of the kidney. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 1293-9. PMID 13679437 DOI: 10.1097/01.Lab.0000087850.69363.59 |
0.371 |
|
| 2003 |
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Macklis R, Thomas PR, D'Angio GJ, Kim T, de Lorimier A, Kelalis P, Shochat S, Ritchey M, Haase G, Hrabovsky E, Otherson HB, ... Grundy P, et al. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group. International Journal of Radiation Oncology, Biology, Physics. 57: 495-9. PMID 12957262 DOI: 10.1016/S0360-3016(03)00598-4 |
0.464 |
|
| 2003 |
Gillan TL, Hughes R, Godbout R, Grundy PE. The Simpson-Golabi-Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis. American Journal of Medical Genetics. Part A. 122: 30-6. PMID 12949968 DOI: 10.1002/Ajmg.A.20279 |
0.708 |
|
| 2003 |
Abramson LP, Grundy PE, Rademaker AW, Helenowski I, Cornwell M, Katzenstein HM, Reynolds M, Arensman RM, Crawford SE. Increased microvascular density predicts relapse in Wilms' tumor. Journal of Pediatric Surgery. 38: 325-30; discussion 3. PMID 12632343 DOI: 10.1053/Jpsu.2003.50102 |
0.42 |
|
| 2003 |
Safford SD, Goyeau D, Freemerman AJ, Bentley R, Everett ML, Grundy PE, Skinner MA. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases. Annals of Surgical Oncology. 10: 136-43. PMID 12620908 DOI: 10.1245/ASO.2003.03.038 |
0.409 |
|
| 2002 |
Filippova GN, Qi CF, Ulmer JE, Moore JM, Ward MD, Hu YJ, Loukinov DI, Pugacheva EM, Klenova EM, Grundy PE, Feinberg AP, Cleton-Jansen AM, Moerland EW, Cornelisse CJ, Suzuki H, et al. Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity. Cancer Research. 62: 48-52. PMID 11782357 |
0.363 |
|
| 2002 |
Kalapurakal J, Li S, Breslow N, Macklis R, Grundy P, Green D, Thomas P, D’Angio G. Influence of radiation therapy (RT) delay after nephrectomy on abdominal tumor recurrence in favorable histology wilms tumor: results of the national wilms tumor studies (NWTS)-3 and 4 International Journal of Radiation Oncology*Biology*Physics. 54: 151-152. DOI: 10.1016/S0360-3016(02)03321-7 |
0.503 |
|
| 2001 |
Hing S, Lu Y, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K. Gain of 1q Is Associated with Adverse Outcome in Favorable Histology Wilms’ Tumors American Journal of Pathology. 158: 393-398. PMID 11159177 DOI: 10.1016/S0002-9440(10)63982-X |
0.541 |
|
| 2001 |
Takamizawa S, Scott D, Wen J, Grundy P, Bishop W, Kimura K, Sandler A. The survivin:fas ratio in pediatric renal tumors. Journal of Pediatric Surgery. 36: 37-42. PMID 11150435 DOI: 10.1053/Jpsu.2001.20000 |
0.329 |
|
| 2000 |
Mason JE, Goodfellow PJ, Grundy PE, Skinner MA. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor. Journal of Pediatric Surgery. 35: 891-6; discussion 89. PMID 10873032 DOI: 10.1053/Jpsu.2000.6911 |
0.394 |
|
| 1999 |
Shearer PD, Valentine MB, Grundy P, DeCou JM, Banavali SD, Komuro H, Green DM, Beckwith JB, Look AT. Hemizygous deletions of chromosome band 16q24 in Wilms tumor: detection by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics. 115: 100-5. PMID 10598141 DOI: 10.1016/S0165-4608(99)00093-X |
0.446 |
|
| 1998 |
Diller L, Ghahremani M, Morgan J, Grundy P, Reeves C, Breslow N, Green D, Neuberg D, Pelletier J, Li FP. Constitutional WT1 mutations in Wilms' tumor patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 3634-40. PMID 9817285 DOI: 10.1200/Jco.1998.16.11.3634 |
0.424 |
|
| 1997 |
Grundy P. Molecular basis of Wilms' tumor Cancer Treatment and Research. 92: 101-123. PMID 9494759 DOI: 10.1007/978-1-4615-5767-8_4 |
0.529 |
|
| 1997 |
Xu Y, Grundy P, Polychronakos C. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor Oncogene. 14: 1041-1046. PMID 9070652 DOI: 10.1038/Sj.Onc.1200926 |
0.465 |
|
| 1996 |
Grundy P, Telzerow P, Moksness J, Breslow NE. Clinicopathologic correlates of loss of heterozygosity in Wilms' tumor: A preliminary analysis Medical and Pediatric Oncology. 27: 429-433. PMID 8926924 DOI: 10.1002/(Sici)1096-911X(199611)27:5<429::Aid-Mpo7>3.0.Co;2-O |
0.48 |
|
| 1996 |
Li FP, Breslow NE, Morgan JM, Ghahremani M, Miller GA, Grundy PE, Green DM, Diller LR, Pelletier J. Germline WT1 mutations in Wilms' tumor patients: preliminary results. Medical and Pediatric Oncology. 27: 404-7. PMID 8827066 DOI: 10.1002/(Sici)1096-911X(199611)27:5<404::Aid-Mpo3>3.0.Co;2-Q |
0.325 |
|
| 1996 |
Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P. Familial Wilms' tumor: A descriptive study Medical and Pediatric Oncology. 27: 398-403. PMID 8827065 DOI: 10.1002/(Sici)1096-911X(199611)27:5<398::Aid-Mpo2>3.0.Co;2-H |
0.397 |
|
| 1996 |
Grundy P, Coppes M. An overview of the clinical and molecular genetics of Wilms' tumor Medical and Pediatric Oncology. 27: 394-397. PMID 8827064 DOI: 10.1002/(Sici)1096-911X(199611)27:5<394::Aid-Mpo1>3.0.Co;2-H |
0.427 |
|
| 1996 |
Matsuoka S, Thompson JS, Edwards MC, Barletta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ, Feinberg AP. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15 Proceedings of the National Academy of Sciences of the United States of America. 93: 3026-3030. PMID 8610162 DOI: 10.1073/Pnas.93.7.3026 |
0.431 |
|
| 1996 |
Green DM, D'Angio GJ, Beckwith JB, Breslow NE, Grundy PE, Ritchey ML, Thomas PR. Wilms tumor. Ca: a Cancer Journal For Clinicians. 46: 46-63. PMID 8548525 DOI: 10.3322/canjclin.46.1.46 |
0.449 |
|
| 1995 |
Grundy P, Coppes MJ, Haber D. Molecular Genetics of Wilms Tumor Hematology/Oncology Clinics of North America. 9: 1201-1216. DOI: 10.1016/S0889-8588(18)30041-8 |
0.524 |
|
| 1994 |
Varanasi R, Bardeesv N, Ghahremani M, Petruzzi MJ, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J. Fine structure analysis of the WT1 gene in sporadic Wilms tumors Proceedings of the National Academy of Sciences of the United States of America. 91: 3554-3558. PMID 8170946 DOI: 10.1073/Pnas.91.9.3554 |
0.511 |
|
| 1994 |
Bardeesy N, Falkoff D, Petruzzi M, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genetics. 7: 91-97. PMID 8075648 DOI: 10.1038/Ng0594-91 |
0.329 |
|
| 1994 |
Coppes MJ, Haber DA, Grundy PE. Genetic events in the development of Wilms' tumor. The New England Journal of Medicine. 331: 586-90. PMID 8047084 DOI: 10.1056/Nejm199409013310906 |
0.396 |
|
| 1994 |
Gessler M, König A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, Cavenee W, Bruns G. Infrequent mutation of the WT1 gene in 77 Wilms' tumors Human Mutation. 3: 212-222. PMID 8019557 DOI: 10.1002/Humu.1380030307 |
0.508 |
|
| 1994 |
Green DM, Beckwith JB, Breslow NE, Faria P, Moksness J, Finklestein JZ, Grundy P, Thomas PR, Kim T, Shochat S. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 12: 2126-31. PMID 7931483 DOI: 10.1200/Jco.1994.12.10.2126 |
0.455 |
|
| 1991 |
Green DM, Breslow NE, Ii Y, Grundy PE, Shochat SJ, Takashima J, D'Angio GJ. The role of surgical excision in the management of relapsed Wilms' tumor patients with pulmonary metastases: a report from the National Wilms' Tumor Study. Journal of Pediatric Surgery. 26: 728-33. PMID 1658286 DOI: 10.1016/0022-3468(91)90021-K |
0.343 |
|
| 1991 |
Cavenee W, Scrable H, Arden K, Grundy P, Koufos A, Gennett I. Beckwith-Wiedemann Syndrome and its associated tumors Cancer Genetics and Cytogenetics. 52: 270. DOI: 10.1016/0165-4608(91)90566-D |
0.462 |
|
| 1989 |
Grundy P, Breslow N, Green DM, Sharples K, Evans A, D'Angio GJ. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 7: 638-47. PMID 2540289 DOI: 10.1200/JCO.1989.7.5.638 |
0.323 |
|
| Show low-probability matches. |